| Sep 4 |
QIAGEN, Lilly to develop Alzheimer's risk detection test
|
| Sep 4 |
QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer’s disease
|
| Sep 3 |
QIAGEN N.V. announces conversion price of new net share settled convertible bonds
|
| Sep 3 |
QIAGEN N.V. announces successful placement of new net share settled convertible bonds
|
| Sep 3 |
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
|
| Aug 30 |
Why Is Qiagen (QGEN) Down 0.3% Since Last Earnings Report?
|
| Aug 30 |
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
|
| Aug 29 |
Qiagen, AstraZeneca expand companion diagnostic pact beyond cancer
|
| Aug 28 |
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases
|
| Aug 27 |
Reasons to Retain QIAGEN Stock in Your Portfolio Now
|
